KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Goodwill & Intangibles (2018 - 2025)

Historic Goodwill & Intangibles for Castle Biosciences (CSTL) over the last 6 years, with Q3 2025 value amounting to $101.8 million.

  • Castle Biosciences' Goodwill & Intangibles fell 788.65% to $101.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $101.8 million, marking a year-over-year decrease of 788.65%. This contributed to the annual value of $106.2 million for FY2024, which is 946.52% down from last year.
  • According to the latest figures from Q3 2025, Castle Biosciences' Goodwill & Intangibles is $101.8 million, which was down 788.65% from $104.1 million recorded in Q2 2025.
  • Over the past 5 years, Castle Biosciences' Goodwill & Intangibles peaked at $132.7 million during Q2 2022, and registered a low of $32.1 million during Q3 2021.
  • Moreover, its 5-year median value for Goodwill & Intangibles was $111.7 million (2024), whereas its average is $102.3 million.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first skyrocketed by 30604.6% in 2022, then plummeted by 3230.92% in 2025.
  • Castle Biosciences' Goodwill & Intangibles (Quarter) stood at $88.9 million in 2021, then surged by 42.09% to $126.3 million in 2022, then dropped by 7.13% to $117.3 million in 2023, then fell by 9.47% to $106.2 million in 2024, then dropped by 4.12% to $101.8 million in 2025.
  • Its last three reported values are $101.8 million in Q3 2025, $104.1 million for Q2 2025, and $77.9 million during Q1 2025.